| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ALBUTEROL SULFATE | 4 |
| 2 | CANDESARTAN | 4 |
| 3 | IRON | 4 |
| 4 | LEFLUNOMIDE | 4 |
| 5 | ACYCLOVIR | 3 |
| 6 | LETERMOVIR | 3 |
| 7 | LEVOTHYROXINE SODIUM | 3 |
| 8 | LEVOTHYROXINE SODIUM ANHYDROUS | 3 |
| 9 | NIVOLUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LETERMOVIR | 3 | 0.0009 |
| 1 | GLUTATHIONE | 1 | 0.0006 |
| 2 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 3 | GANCICLOVIR SODIUM | 2 | 0.0002 |
| 4 | CANDESARTAN | 4 | 0.0001 |
| 5 | VALGANCICLOVIR | 2 | 0.0001 |
| 6 | VORICONAZOLE | 3 | 0.0001 |
| 7 | AMPHOTERICIN B | 1 | 0.0001 |
| 8 | ETHYL ALCOHOL | 2 | 0.0001 |
| 9 | RIBOCICLIB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 6 | Antirheumatic Agent [EPC] | 4 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 3 | 0.0000 |
| 8 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0000 |